Migraine Breakthrough: Not So Fast
Many experts believe the approval of Aimovig marks the dawn of a new era in the treatment of chronic sufferers of migraine. For some sufferers it is, but for the majority it is not.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Source Type: news